PleusSEichenlaubMDablaPK, et al. Clinical assessment and acceptance criteria for continuous glucose monitoring (CGM) system performance: a proposed guideline by the IFCC Working Group on CGM. Clin Chim Acta. 2025:120728. doi:10.1016/j.cca.2025.120728.
2.
SandbergSFraserCGHorvathAR, et al. Defining analytical performance specifications: consensus statement from the 1st Strategic Conference of the European Federation of Clinical Chemistry and Laboratory Medicine. Clin Chem Lab Med. 2015;53(6):833-835. doi:10.1515/cclm-2015-0067.
3.
KrouwerJS.Minimum requirements for continuous glucose monitors: what does it mean. J Diabetes Sci Technol. 2025;19(5):1417-1418. doi:10.1177/19322968251343645.
4.
VigerskyRAShinJ.The myth of MARD (mean absolute relative difference): limitations of MARD in the clinical assessment of continuous glucose monitoring data. Diabetes Technol Ther. 2024;26(S3):38-44. doi:10.1089/dia.2023.0435.
5.
KrouwerJS.Validation of the Diabetes Technology Society error grid. J Diabetes Sci Technol. 2025;19(3):853-854. doi:10.1177/19322968251320653.
